The delivery of intensity modulated radiation therapy ͑IMRT͒ using dynamic multileaf collimation ͑DMLC͒ accounts for about 40% of all treatments on eight multileaf collimator ͑MLC͒-equipped linacs currently at the central and satellite facilities of the Memorial Sloan Kettering Cancer Center ͑MSKCC͒. These numbers have been steadily growing for the past 6 years. Treatment with IMRT has been used for a variety of cancers, including tumors of the prostate, head and neck, breast, paraspinal regions, and brain. To ensure that patients are treated in an accurate, efficient, and safe manner, we have developed a comprehensive QA program including mechanical quality assurance, which monitors known potential weaknesses in the MLC device itself, and verification of patientspecific treatments, to confirm the reliability of new software and to identify errors introduced through human interaction with individual patient's plans. This paper presents the reasoning, methodology, and results for mechanical, dosimetric, and electronic tests that are conducted at MSKCC.
I. INTRODUCTION
Intensity modulated radiation therapy ͑IMRT͒ addresses the clinical need to improve tumor control without compromising normal tissues by facilitating higher, more conformal tumor doses relative to conventional three-dimensional conformal radiation therapy ͑3DCRT͒.
1 Interest in intensity modulation ͑IM͒, has surged in the past few years due to a number of technical innovations, specifically inverse planning and radiation delivery using dynamic multileaf collimation. Compared to 3DCRT, certain components in the IMRT process are more obscure to the user. Thus, special quality assurance procedures are required, in addition to what is currently performed for 3DCRT using MLC. Hardware and software are still relatively new to many users, and the potential for error is unknown. The relationship between monitor unit ͑MU͒ setting and radiation dose for IM beams is much more complex than for non-IM fields. The leaf sequence computer files, which control the MLC position as a function of MU, are large and do not lend themselves to simple manual verification. The ''verification'' port film for each IM treatment field, usually obtained with the MLC set at the extreme leaf positions for that field to outline the entire irradiated area, does not verify the intensity modulation pattern. Finally, in IMRT using DMLC ͑the so-called sliding window technique͒, a small error in the window ͑or gap͒ width will lead to a significant dose error. 2, 3 Given that the present MLC were not specifically designed for used in the dynamic mode, such uses may place mechanical demands on them beyond what was intended. In earlier papers, we provided an evaluation of the mechanical and dosimetric aspects in the use of a MLC in the dynamic mode. 2, 4 Mechanical tolerances are significantly tighter for DMLC than for static MLC treatments. Transmission through the leaves and through round leaf ends and head scatter were shown to be significant to the accuracy of radiation dose delivery using DMLC. With these considerations, we concluded that the present DMLC hardware and software are effective for routine clinical implementation, provided that a carefully designed routine QA procedure is followed to assure the normality of operation.
In our earlier studies, an evaluation of the long-term stability of DMLC operation had not yet been performed. Thus, as an added safety measure, we carried out dosimetric verification at the isocenter for every IMRT field for the first 380 patients treated with IMRT-DMLC. Dosimetric evaluation of the entire field of each IM beam, using standard verification tools ͑i.e., ion chambers and film͒, would have overtaxed the medical physics resources and was judged not to be necessary. Nevertheless, the complexity of the IMRT relative to 3DCRT with static MLC fields required a reevaluation of current methodology of treatment verification. The use of EPID ͑electronic portal imaging device͒, which potentially provide a more efficient, but certainly not ''cost-free'' method, awaits improvements in the speed of data acquisition and in spatial resolution. 5 Our current approach integrates existing methods, combining periodic QA and computer verification, to provide the necessary quality assurance in a safe and efficient manner.
This paper describes the current status of our QA program for DMLC. We distinguish between the routine QA of DMLC performance ͑machine QA͒, and the verification of patient-specific IM fields using DMLC ͑treatment QA͒. Since our initial DMLC implementation in 1995, there have been a number of incremental improvements to our overall QA program. These include methods of mechanical and dosimetric measurements, and software tools developed either by us or by the manufacturer.
II. METHODS AND MATERIALS

A. Routine machine QA
The alignment of the leaves in the direction of leaf motion is initially performed with the calibration procedures recommended by the manufacturer. ͑MLC Systems and Maintenance Guide, 1995, Varian Associates Inc., Palo Alto, CA.͒ ͑Preliminary MLC Systems and Maintenance Guide, 1999, Varian Medical Systems, Inc., Palo Alto, CA.͒ Particular attention should be given to the calibration of the gap and the parallelism of the banks of leaves to each other ͑relative skewness͒, since the accuracy of these parameters will affect the dose delivered to the patient. If DMLC treatments are intended, then we suggest that the gap between opposing leaves should be calibrated to within a tolerance of 0.001Љ ͑0.025 mm͒ at the MLC.
During ''initialization'' of the MLC, which should be performed at least once daily ͑usually in the morning during machine warm-up͒ as suggested by the manufacturer, the leaf positions are automatically calibrated by an optical system. However, during the day one or more of the MLC leaves may go out of calibration, which could be due to long-term gradual performance degradation of individual motors that have been exercised extensively. This behavior is associated with a loss of counts by the leaf position encoder, an integral part of the motor assembly. Two methods are currently used to identify encoders that exhibit excessive count loss. The concept of radiographic film to provide a quick visual assessment of the leaf calibration has been described in an earlier paper. 4 Briefly, Kodak V2 Ready Pack film is placed on the treatment table and exposed to a DMLC field that produces a matrix of high intensity regions, 1 mm wide and spaced 2 cm apart. The lowest energy, typically 6 MV x-rays, is used without buildup to obtain a sharp image. This test, performed semi-weekly near the end of the treatment day, but at least 4 hours after MLC initialization, takes 5-10 min, inclusive of film processing and a visual evaluation. Physicists evaluate these films exposed by therapists; a leaf out of position by greater than ϳ0.2 mm on successive films will have its motor replaced. We developed a more objective evaluation using a film digitizer, associated graphical output and analysis, but find it to be unnecessary since variations as small as 0.2 mm in the gap width of a leaf pair can be detected visually. In either case, the errant positioning of leaves can be easily identified. The second method uses a software utility, the ''optical calibration move,'' provided by the manufacturer for pre-Millenium MLC. Available in the MDIAG software ͑Varian Medical Systems, Inc., Palo Alto, CA͒, this utility quantifies the loss of counts incurred by individual encoders during a predefined leaf exercise. The leaves are stepped through a calibration cycle, an exercise cycle, and a second calibration cycle. The change in counts between the two calibration cycles assesses the ability of individual leaves to maintain their calibration during DMLC operation. The Millenium MLC Diagnostics Program, NTDIAG, ͑Varian Medical Systems, Inc., Palo Alto, CA͒, provides other utilities, which should allow a similar analysis.
We are also concerned with the stability of the MLC carriages. We have previously described tests for monitoring the stability of MLC operation with ion chambers at the central axis, as the DMLC output for a narrow sliding window is a sensitive monitor of gap width variation. 2, 6, 7 The loads imposed by the carriages, produce a mechanically and dosimetrically measureable variation in the gap width as the gantry and collimator is rotated. Long-term results of such ionization measurements will be presented.
Furthermore, the two banks of leaves should be aligned parallel to each other. This alignment may also be affected by gravity causing sag and backlash in the MLC carriage drive and support assemblies. Thus, the relative skewness of the banks of leaves is checked periodically, and at a number of gantry and collimator angles. Shifting the ion chamber offaxis and repeating the DMLC output measurement can detect variation in gap width along the breadth of the carriages. Differences due to variations in interleaf leakage should be quantified with leakage measurements and removed. Alternately, a linear diode array, the Profiler ͑Sun Nuclear Corporation, Melbourne, FL͒, aligned perpendicular to the direction of leaf motion, can measure the relative DMLC output for all the leaves simultaneously. The 46 diodes are located at 0.5 cm intervals, which when mounted to the head of the machine at about 70 cm from the source, project at 0.7 cm intervals at the plane of the isocenter. Thus, the diodes see varying amounts of interleaf leakage, causing their relative response to be somewhat noisy, even when the leakage is measured and removed individually, possibly due to sag in the diode array mount itself. We have quantified the variation along the gap by first applying linear fits to the diode readings.
We use a sliding window to verify dosimetrically that the leaf gaps are accurate at off-axis points; i.e., the correction parameters in the MLCTABLE file are being executed properly. Relative dose profiles are compared for an open field and a 1.0 cm wide sliding window. The shape of the dose profile for an open static field should be closely replicated for the same field size generated by a sliding window moving at a constant speed. With the lower jaws symmetrically set to 12 cm, the DMLC field begins with the window under one jaw and ends with the window under the other jaw such that the rounded ends are completely shielded at the initial and final stages of beam delivery. Due to the limits of leaf travel ͑14.5-15.0 cm͒ within a single DMLC field, it is necessary to shift the jaws and the DMLC field asymmetrically in order to evaluate leaf-positioning accuracy at extended distances from the axis. Ion chamber measurements are obtained at 1 cm intervals across the width of the field at an arbitrary depth in phantom, and are normalized to the measurement at the axis. In practice, transmission constitutes a substantial portion of the total dose in this field and is sufficiently variable across the field to warrant a correction on a point-by-point basis. For this purpose leaf transmission measurements are made for each bank of leaves completely blocking the field in the same geometry as the DMLC measurements.
Using the concept of the effective gap offset, 2,7 we compare the contributions of the added fluence through the round leaf ends for all of our MLC. This offset is the amount that a leaf would need to be retracted to add the same fluence as is transmitted through the round leaf end. Our technique uses dynamic fields and ion chamber measurements as described previously, 6 with analytical fitting to obtain the effective gap offset. 2, 7 B. Verification of patient treatment using IMRT-DMLC As an independent MU check, we measured the dose in phantom for all fields for the first 380 patients treated with IMRT-DMLC. An ion chamber was placed at a reference depth ͑16 cm for treatment of the prostate͒ at isocenter and a measurement was taken for each IM field, and for a reference 10ϫ10 cm 2 MLC field, for which the dose is known. The measured ionization is then converted to dose delivered to the isocenter in the patient ͑using effective pathlength and TPR͒, and compared to the prescribed dose. Since January 1999 an independent MU calculation program has been in use. Persons not involved with the treatment planning dose calculations devised these backup calculations using the leaf sequence files, modified by a fixed leaf position offset to correct for the round edge, as input to a pencil beam algorithm. This computer program is now our principal method for independent MU calculation.
For verifying the radiation distribution within IM fields, film dosimetry with its high spatial resolution is best. Our film technique using flat and cylindrical phantoms has already been described. 2, 6 Subsequently, certain precautions have been added during calibration and processing. For quality control, additional films are exposed to a standard dose, and interspersed with respect to the calibration and verification films to assess variation in film processing. Each film is also flashed along its edge with a sensitometer just before processing to assess, as yet unexplained, variations in film density ͑up to 10%͒ observed for a small percent ͑ϳ5%͒ of films within the same batch. With these precautions, and corrections if appropriate, the reproducibility of the measured dose is ϳ1%. Commercial hardware ͑Lumisys Corp, Sunnyvale, CA; Agfa Arcus II, Ridgefield Park, NJ͒ and software ͑Radiological Imaging Technology, RIT 113, Colorado Springs, CO͒ are used for film scanning and digitization. Density to dose conversion and comparison between the measured and the planned dose distributions are currently handled by in-house software. After recomputation in phantom the calculated and the measured dose distribution are spatially registered, and an overlay of isodose curves and a map of dose difference distribution are produced for each field.
In most cases there are several versions of an IMRT treatment plan for the same individual patient. To ensure that the approved version is used for treatment, the MSKCC treatment planning software automatically assigns and attaches a unique identification number to each version of the patient's data. This number is recorded in the computer file, printed on printouts and graphical plots, transferred with the leaf sequence DMLC file, and subsequently displayed with the patient name and field name at the MLC workstation. Consistency between these values is a prerequisite for treatment.
Before the first treatment session, ''double exposure'' portal films for all the IM fields as well as standard orthogonal images are obtained and compared with the corresponding digitally reconstructed radiographs ͑DRR͒, computed at the same 135 cm SSD ͑as the portal films͒. The portal images are MLC-shaped fields with paired leaves at their initial and final positions for the DMLC field; the superior and inferior borders are defined by the upper jaws. All the images are displayed with a 2 cm spaced grid to facilitate spatial comparison.
Daily verification of correct leaf positions relies on software checks provided by the MLC manufacturer and MSKCC. Each leaf sequence file contains a check sum added by the treatment planning system to ensure file integrity. Since monitored leaf positions can deviate from the actual leaf positions if the primary motor encoder drifts from its calibrated state, secondary leaf position indicators provide a backup to the primary encoders, inserting an interlock when discrepancies between these readouts exceed approximately 2 mm. Primary encoders must also agree with the prescribed leaf positions in the leaf sequence file as a function of MU, also within 2 mm in our scheme, 2 or the beam is held-off until the tolerance is achieved.
Record and verify software developed at MSKCC ''eavesdrops'' on the communications between the MLC and the MLC controller, comparing initial and final leaf positions for each field. Recently we have begun to replace our record and verify system with the VARiS Treatment ͑Varian Medical Systems, Palo Alto, CA͒ software module, which adds the convenience and security in its ability to transfer treatment planning data electronically to the treatment machine control computers.
After each IM beam delivery, a DMLC log file report summarizes the discrepancies between the prescribed and monitored leaf positions. These treatment summaries are useful as a verification of the proper delivery of the DMLC field. The DMLC log files can be used to generate the delivered radiation fluence profiles, permitting the calculation of the delivered dose distributions ͑within the uncertainty due to leaf calibration and mechanical backlash͒ and their comparison with the planned dose distributions.
III. RESULTS AND DISCUSSION
A. Routine machine QA
Prior to dynamic therapy, our routine quality assurance testing for the MLC had been to examine the position of the light field edge defined by the leaves on graph paper. This simple test, commonly used to check calibration of the jaw collimators, is consistent with the sole function of the MLC for static fields, that is, to shape the field edges with a modest degree of accuracy; 1 mm error in the calibrations of the jaws and leaves can be tolerated. However, for DMLC treatments using the sliding window technique, the gaps between opposing pairs of leaves, are critical to dose delivery throughout the target; leaf movements need to be executed much more precisely. Therefore, a much tighter tolerance of ϳ0.2 mm in gap width is needed for DMLC.
One concern in DMLC delivery, error in leaf position, appears to be related to the amount of usage of individual leaf motors. Figures 1 and 2 show the record of replacement of leaf motors for three MLC that have been used in IMRT. Since 1995 approximately 70% of patients ͑ϳ25 patients/ day, 5 fields/patient͒ on two machines, 245 and 445, have been IMRT prostate patients. These MLC have been used for static MLC treatments since 1992. In Fig. 1 , the leaf motors that have been replaced at least once are denoted by the gray shading, with the numbers indicating multiple replacements that have occurred for the specific motors. The solid lines in Fig. 2 indicate the chronology of the cumulative number of motor replacements for the three MLC. Also indicated are the approximate dates that the respective static MLC and DMLC usage were initiated. We have gradually gained an understanding about DMLC operation since the initiation of IMRT treatment at MSKCC. With the incremental improvement of the DMLC QA and fault detection programs discussed later in this section, leaf drive motors have been replaced at a steady rate since 1998. However, during the years prior to this, leaf position errors were increasingly detected, but the solution was evolving from increasing the frequency of reinitialization to the realization that marginal motors needed to be replaced as part of the QA program. Based on our QA records, the dashed lines would have been the chronology if MLC motor replacement took place at the first signs of failure, as we have done in recent years. It is interesting to note that leaf motor problems became more frequent only after the initiation of DMLC treatment. A corroborating observation is that motor replacement are mostly located in the central portion of the MLC, consistent with the fact that only the central 10 leaf pairs are used for treatment of cancer of the prostate, the prevalent disease site treated with IMRT in Rooms 245 and 445.
One source of leaf position errors stems from the losses of counts by the primary encoders, which become more severe during the course of the treatment day, assuming the MLC is initialized in the morning. On occasion that the chronic loss of counts of a primary encoder becomes excessive, leaf position errors could exceed 0.5 mm at isocenter. Reinitializing the MLC will temporarily alleviate the problem, but position errors may go unnoticed since the secondary position interlock is triggered only when the discrepancy between the primary and secondary readouts reaches ϳ2 mm at isocenter. To safeguard against such errors, potential encoder problems are identified using the semi-weekly film test; the questionable motors are then replaced at the earliest convenience. Though rare, the largest leaf position error, which is not detected by the secondary position monitor, ϳ2 mm, will introduce a 10% dose error for one leaf pair in a typical DMLC field with an average window of 2 cm. This condition can exist intermittently for 2-3 days before detection.
Sample results of the ''optical calibration move'' test utility for one bank of leaves are shown in Fig. 3 . The change in motor counts during a leaf exercise cycle is detected by the manufacturer's software. In this example, the test was executed three times, and the results are plotted versus leaf number. Given that ϳ300 motor counts correspond to 1 mm at isocenter, leaf #17 would be considered unacceptable, and its motor would be replaced. The reliability of this software relative to the film test for detecting failing motors has not been thoroughly examined.
Another cause of leaf position error is motor fatigue. After a long period of use, a leaf may appear sluggish and unable to maintain its rated leaf speed of 3 cm/s. Such behavior, often associated with a failing motor, is visually obvious as the leaves are extended or retracted, and so a specific QA test is not required. Such a motor is replaced at the earliest convenience to avoid dose inaccuracy and excessive beam holdoffs. If uncorrected, this condition eventually leads to a stuck leaf, perhaps during patient treatment. We also observe that motor fatigue often occurs at the same leaf positions, indicating that mechanical stress in the leaf assembly may accelerate the problem. This is most apparent for the MLC in Room 445 ͑Fig. 1͒; the motor for leaf B15 had been replaced 5 times before the leaf assembly was replaced. Subsequently, the problem has not recurred at that position.
The long-term stability of the MLC calibration is monitored with monthly ion chamber measurements. The ionization data for the same reference DMLC field are shown in Fig. 4 for three MLC for the period from early in 1998 to the present time. The stability in radiation output, an indication of MLC calibration during this period, is within 1% for all three machines. Given the gap width of 5 mm for the reference DMLC field, the above translates to ϳ0.3% for typical clinical fields with an average gap width of ϳ2 cm. Prior to this period, larger variations were observed for the MLC in Room 445; this was eventually attributed to excessive carriage movement and led to the replacement of the carriage bearings at the end of 1998. Small changes in DMLC output for 445, at times indicated by the dashed lines in Fig. 4 , correspond to adjustments to the calibration parameters in the MLCXCAL file.
The influence of gantry and collimator angles on gap width error, as measured with an ion chamber with the ref- The ratio is plotted for a 3 year period for three MLCs. A 3% change in the ratio corresponds to a 0.2 mm change in the gap width. Abrupt changes for one MLC in room 445 correspond to adjustments to the MLCXCAL file in conjunction with mechanical realignments. The small gradual downward trend, ϳ0.005 mm, for the other two MLCs is unexplained.
FIG. 5. Stability of DMLC output at the central axis vs gantry and collimator
angle. Ion chamber measurements in air of the output for a DMLC field with a 0.5 cm gap are normalized to the output for a static reference field, 10 ϫ10 cm 2 . This is done for the six gantry-collimator angle combinations shown. The data are then renormalized to the 0°-0°combination. The ratio is plotted for a 3 year period for one MLC ͑Room 445͒. A 3% change in the raio corresponds to a 0.2 mm change in the gap width. Abrupt changes in the DMLC output correspond to mechanical repairs: *, replacement of carriage bearings; **, adjustment of carriage bearings; and #, adjustment of carriage belt tension.
cal repairs: replacement and adjustments of carriage bearings and the adjustment of the carriage belt tension. In contrast, there is very little variation ͑р 0.5%?͒ for the MLC in Room 245 ͑data not shown͒. This difference between the MLC is attributed to the dissimilar magnitude of backlash particularly in their carriage mechanisms. These output measurements have been confirmed by mechanical measurements of the gap using feeler gauges and dial indicators to quantify carriage movement with gantry rotation. With the exception of Room 445, the variations of output with gantry and collimator angle have been relatively stable over this same 2-year period.
The data in Figs. 4 and 5 provide information about the central axis only, where the measurements are made. Although our film and ion chamber tests in combination check the performance of all MLC leaves over time, they may not detect small but non-negligible variation in the gap width for off-axis leaves due to carriage misalignment or backlash. Such variation would be accentuated at certain gantry and collimator angles, due to mechanical limitations of the MLC and the effects of gravity. Supplementary data, obtained with a linear diode array for the MLC in Room 245 for gantry angles of 90°and 270°, is shown in Fig. 6 . The individual diode readings are normalized to the readings with both the gantry and collimator at 0°; this removes most of the noise introduced by the variable interleaf transmission and the fact that the diode spacing and leaf widths are different. The residual scatter in the data points in Fig. 6 is likely due to small shifts in the detector with gantry angle and inherent variations in the diodes' responses at very low dose rates. Fitting these data points to straight lines yields the dashed lines for gantry angles of 90°and 270°. In terms of the overall trend, small variations were observed on the central axis, consistent with the ion chamber measurements, but larger variations exist at off-axis points. Apparently, the weight of the MLC induces backlash in the carriage bearings, manifested as skewness of the leaf banks relative to the 0°-gantry position. Some backlash is unavoidable in mechanical systems; fortunately, such variations, as observed here at 90°and 270°, tend to compensate each other during treatment. It is noteworthy that the data obtained with the ion chamber and diode array have been stable during the 2-year observation period for this machine. Nevertheless, output vs gantry angle is variable among the MLC, and output changes over time may indicate mechanical problems.
On a less frequent schedule, perhaps annually, we check the gap-width accuracy at off-axis positions with ionization measurements. Relative dose profiles ͑i.e., normalized to the dose at the central axis͒ for 12 cm wide static rectangular fields defined by the jaws are compared with the same size fields produced by a 1 cm wide sliding window in Figs. 7͑a͒ and 7͑b͒ for 6 MV x-rays. Figure 7͑a͒ shows the static field and DMLC field profiles and the ratios of these profiles for each of three fields, centered at the axis and at Ϯ8 cm offaxis at a depth of 10 cm. Near the central axis, Ϯ5 cm, the profiles agree within 0.5%; however, at 10 cm from the axis, the ratio of the profiles decreases by ϳ2%. This decrease is not due to changes in the gap width, as the following analysis shows. For this 1 cm sliding window ͑15 cm of leaf travel͒ for the Millennium 120 MLC, the duty cycle is only 0.08, and the dose transmitted through the leaves is ϳ20% of the total output. Figure 7͑b͒ shows that the measured transmission also decreases with increasing off-axis distance, to 92% of the central axis transmission at 10 cm off-axis. Indeed, Fig. 7͑b͒ shows that the ratios of the profiles for the DMLC fields and the static fields are much flatter, once the transmitted component of the dose is removed from the DMLC readings. The residual unflatness in the ratios, approximately Ϯ0.5%, is likely due to oblique scatter mainly from the edge of the lower jaw, which ''sees'' a narrower DMLC window near the field center than near the field edge. Thus, the width of the gap is relatively constant across the field, as even a 0.5% dose change for a 1 cm sliding window would correspond to only a 0.05 mm gap-width variation. This indicates that both the leaf position corrections within the MLCTABLE file are correct and that DMLC execution is performed correctly. Note that the dose variations due to transmission and scatter are, for the most part, artifacts of this test. Under clinical conditions, where the gaps are typically 2-3 cm wide and the duty cycles are 0.2 to 0.5, dose variations from these sources would be less than 0.5%.
Effective gap offsets measured for six MLC ͑one Mark 1, three Mark 2s, and two Millennium 120s͒, are summarized in Fig. 8 for 6 and 15 MV x rays. For the same nominal energies, variation in the offset value was within Ϯ0.15 mm at all positions, although this range varied among the MLC. Except for the MLC in Room 442, the variation in the offset value at the central axis is within Ϯ0.05 mm for beams with the same nominal energy. The lower offset for the MLC in Room 442 may be at least partly related to the slightly lower beam energy observed for this 6 MV beam. Dual energy machines showed a consistent increase in the effective offset, ϳ0.1 mm, for the higher energy beam. This energy related shift is consistent with midleaf transmission data that we have observed for these MLC. Multiple sets of measurements for some MLC indicate good reproducibility. Note that this measurement also includes the effect from the uncertainty of the leaf gap calibration and the limitations of the mechanical components of the MLC system. In theory and verified experimentally, the measured results are independent of the chamber and the phantom.
B. Verification procedure for patient treatment using IMRT-DMLC
Dose-based verification
Pre-treatment checks and then continuum monitoring of patient data at key points during the course of treatment have been designed to prevent potential errors. This patientspecific QA process complements the machine QA program, ensuring that the planned DMLC data for individual patients is properly documented, and then transferred to and delivered by the MLC control system correctly.
One pre-treatment check that we initially adopted was to measure point doses or 2D dose distributions in a phantom for comparison with calculated results in the same geometry. The ratios of measured and prescribed dose for approximately 400 prostate patients are shown in Fig. 9 . Each point on the graph represents the ratio of the total measured to the total calculated dose for the five DMLC fields delivering the prescribed 180 cGy. The average ratio and its standard deviation for all the patients are 0.993 Ϯ 0.8%. When the ratio of the total dose exceeded 2%, or the ratio of an individual field exceeded 5%, further investigation including film dosimetry was conducted. Usually the discrepancy can be at- FIG. 8 . Effective gap offsets derived from the outputs of DMLC fields for six different MLCs using the method described for Fig. 7 . Measurement are made for both 6 and 15 MV x rays, for Mark 1 Mark 2, and Millenium models, and at the central axis ͑CAX͒ and at 5 and 10 cm off-axis. Repeat measurements indicate excellent reproducibility.
tributed to tongue and groove effects and/or setup uncertainties when the isocenter was located in a region of high dose gradients. Note that the finite size as well as the exact placement of the ion chamber may influence the verification of the isocenter dose of a DMLC field, if it integrates over an area of nonuniform dose distribution. This problem is exacerbated when IMRT is implemented for the treatment of cancers of the head and neck, where the degree of intensity modulation is greater than that for the treatment of cancer of the prostate. In part for this reason, and because of the increasing number of IMRT patients, we developed a more efficient strategy to verify MU, which will be discussed later in this section.
We have used film dosimetry effectively to verify dose distributions in 2D. With proper controls during film exposure and processing, the results obtained are generally within 2% of calculated 2D dose distributions for small to moderate field sizes. An example of such a comparison is shown in Figs. 10͑a͒ and 10͑b͒ for a posterior field in a typical sevenfield IMRT nasopharynx treatment. Figure 10͑a͒ displays the film measurement in a flat homogeneous phantom at 10 cm depth overlaid with the dose distribution recalculated in the phantom geometry. The dose within this field varies from less than 10 cGy to the cord region up to about 30 cGy. Comparison of these dose distributions in phantom to verify the dose delivered to the patient assumes that the calculated to measured dose ratios in the phantom and patient are similar in the absence of large inhomogeneities. The dose difference distribution in Fig. 10͑b͒ highlights differences between the measurement and the calculation. For the most part, these differences are found in the high gradient regions at the field edges. For larger fields, greater than 15 cm, and the lower 6 MV beam in particular, we have observed a reduced radiographic response near the periphery of the fields. Ion chamber measurements suggest that this may be due to the energy dependence of film sensitivity. Possibly, the reduced scatter to primary ratio near the periphery of the field relative to the center, where the film is calibrated, results in the decreased sensitivity.
Other verification tools have been tested with varying degrees of success. The development of the electronic portal image device ͑EPID͒ for DMLC dose verification may eventually provide a more efficient method than film. EPID are already found in many modern therapy facilities. Software has been developed to measure exit dose from IMRT fields and/or dose distributions with EPID, and to relate the measured data to the delivered dose in the patient. 5 At present, such applications are hindered by technical difficulties in data acquisition, but these should be resolved with the new generation of detectors and software.
We have found in-vivo thermoluminescent dosimetry ͑TLD͒ to be unreliable for dose verification for DMLC fields. As is our procedure for conventional static fields, packets of three TLD chips were placed under bolus on the skin of patients, usually at the central axis. The measured doses when compared to those calculated for the same geometry occasionally deviated by as much as 10%. Similar measurements for the same DMLC fields, but with the TLD attached to the surface of a phantom, yielded better agreement of р3%. Thus we concluded that in-vivo TLD was more susceptible to dosimetric error due to the combined effect of the uncertainty in the placement of the chips on the surface of a patient and the dose gradient of DMLC fields.
Based upon the application of the Profiler diode array for commissioning dynamic wedges, 8 we thought that it might be useful for verifying DMLC profiles. However, certain features of the diode array initially presented problems. Its internal triggering mechanism requires a threshold radiation level, otherwise the device is inactive. The threshold level is greater than the MLC leakage, which is ϳ2% of the open field dose rate. Thus a significant portion of DMLC dose, ϳ5%, delivered as leakage at very low dose rates, is not integrated by the array. On the advice of the manufacturer, we bypassed the internal trigger, hardwired the array to the accelerator, and triggered it with the beam pulse signal. This modification solved the triggering issue, but revealed nonlinearity at very low dose rates. According to the manufacturer, an inherent characteristic of diodes, ''indirect recombination,'' causes the array to under-respond at low dose rates. ͑Private communication-Bill Simon, Sun Nuclear Corp., Melbourne, FL.͒ This characteristic introduces a dose uncertainty of ϳ2% for typical DMLC fields.
Computer-based verification
The routine use of dose-based verification techniques, as described above, is labor-intensive, especially if one wishes to verify the 2D dose distributions for each IM field. Although film and ion chambers are still used periodically when commissioning new hardware and software and evaluating new anatomical sites for IMRT, we have adopted more efficient alternate approaches for routine verification. The main features include software to independently check the MU calculations, software and manual checks to ensure that the plan is correctly transferred from treatment planning to the treatment machine, and software to monitor leaf positions during treatment and interrupt the delivery in the event of a malfunction.
It is a standard practice in radiotherapy to have two independent calculations of the MU to be used in patient treatment. For static fixed field treatment ͑with either alloy blocks or MLC͒, independent calculations can be easily carried out. The relationship between MU and prescribed dose is complicated for DMLC, with the principal variant being the duty cycle, to which MU is inversely related. The duty cycle typically varies from 0.2 to 0.5 for points in high dose regions of a DMLC field. The duty cycle also affects the fractions of the total dose from radiation leakage and transmission through the round leaf ends, ϳ5 and 10%, respectively. Furthermore, for the consideration of output factor, the ''field size'' information of 200 segments per DMLC field would have to be accounted for. Consequently, manual calculation as the independent MU check is not practical. Other investigators have reached similar conclusions as they developed their own independent dose calculations for MU verification.
9,10 Both of these methods differentiate a fixed primary region near the point of calculation and a Clarkson summation for the more distal regions. This approach is well suited to the broad beamlets encountered with step-and-shoot delivery; however, much greater resolution is required for the sliding window delivery to accurately simulate the ''primary'' component. For this reason we use a pencil beam algorithm for the independent calculation. Details of this independent calculation will be presented in a forthcoming publication.
Processing of planned patient data is not failsafe, as human interventions are still necessary at various stages, particularly during the transfer of the data from the planning system to the delivery system. Components of multiple versions or sequential phases of a patient's treatment plan, and even components of plans for different patients, may appear very similar and have similar leaf sequence patterns. Features are also less distinguishable since the MU and other beam parameters are calculated by the system and are not easily recognized or verified by the human operator. In order to avoid erroneous or accidentally mismatched patient data the leaf position/MU sequences executed by the MLC are linked to the physician approved dose distributions through a series of software checks developed at MSKCC and by the MLC manufacturer. As described in the Methods and Materials section, unique IDs attached to each component of the treatment plan, check sums within leaf sequence files, and record and verify validation of initial leaf positions at setup confirm that the correct data is to be used for treatment. Portal images with film and EPID are acquired with the leaves at their extreme positions in the DMLC field, for comparison with the aperture superimposed on the corresponding digitally reconstructed radiograph ͑DRR͒.
1 Of course, only the outline of the DMLC field is imaged, neither verifying the intensity modulation within the DMLC port, nor confirming the dose sparing to critical structures overlying the target. Here again, the development of EPID holds significant promise.
Log files, generated by the DMLC control software, summarize the deviations of the leaves from their prescribed positions for leaves that were moving during the DMLC treatment. Since the spatial information in the log file is from the primary MLC encoders, neither the accuracy of the encoders' calibration nor the backlash in the leaf and carriage mechanisms is accounted for. Thus, the log files do not contain ''actual'' leaf position data; rather, from the perspective of the encoders, they document the deviation of the leaves from their intended positions during DMLC delivery. Nevertheless, the log file report is a useful tool for comparing leaf motions under different stresses to the MLC. For example, a log file analysis of the effects of repeated beam holdoffs, invoked by gating signals, on IMRT dose delivery has been reported. 11 During DMLC acceptance testing, we use log files to study the impact of gantry and collimator rotations on leaf positioning.
On average, the positional deviations of pairs of opposing leaves tend to compensate each other, resulting in an average gap error, a better indicator of DMLC performance, which is much smaller than 0.2 mm. Thus, deviations of individual leaves are related only indirectly to the quantity of interest, the accuracy of the delivered dose. For this reason, we generate dose distributions, with our treatment planning system, based upon the leaf positions supplied in the log files, and compare them with the planned dose distributions. One example is shown for a head and neck field, with the overlay of two dose distributions and their dose difference plots in Figs. 11͑a͒ and 11͑b͒. The maximum difference ϳ0.3 cGy ͑ϳ1% of the average dose within the field͒ is observed in the high gradient region. The average discrepancy is ϳ0.05 cGy; corresponding to average gap errors of Ͻ0.1 mm for this field.
In our opinion, having established the relationship between DMLC leaf positioning and dose delivery during commissioning, combined with frequent QA measurements targeting leaf motor failure and carriage backlash, then it should only be necessary to verify leaf positions approximately to ensure accurate dose delivery. In other words, leaf position monitoring software is sufficiently restrictive such that undetected leaf position errors do not lead to significant dose errors when averaged over the course of treatment. Thus, we believe that there are sufficient safeguards to ensure the delivery of the correct dose distribution for DMLC fields, without resorting to routine dose-based verification.
IV. SUMMARY AND CONCLUSIONS
In our implementation of DMLC for IMRT we identified three critical processes for ensuring that the correct dose is delivered. As a prerequisite to the clinical application of IMRT and complementing the ideas presented in this paper, there must be an acceptance testing and commissioning process to establish the capability for accurate DMLC-IMRT, both from the treatment planning and delivery perspectives.
The second is a routine DMLC QA process to periodically check and calibrate the DMLC performance, ensuring that when the treatment parameters are correctly set, the correct dose is delivered. We have stressed that gap width is the critical parameter for accurate dose delivery with DMLC, and MLC position calibration and leaf motor fatigue are recognized as primary sources of gap inaccuracy. Both are systematic in nature, and can be detected by our appropriately scheduled QA procedures. The tests include semi-weekly film exposure performed by therapists and monthly measurements performed by physicists using DMLC sequences to confirm the leaf positioning/gap accuracy. These measurements can also track the long-term stability of DMLC performance.
The third is a patient-specific QA process to minimize the possibility of human error. This includes QA of the treatment plan data, the transfer of the data to the machine and MLC control systems, and the continued monitoring of the data over the course of treatment to detect alteration/corruption and to prevent the use of the wrong DMLC files for individual treatments. As detailed in the paper, this QA process has evolved with time and has included the use of ion chambers, film dosimetry, patient data management software, and computerized independent MU check. It is likely that this program will be further incrementally altered and improved.
In summary, the combination of commissioning, routine machine ͑MLC͒ QA, and patient-specific QA, provides sufficient assurance that the planned dose distributions are delivered in DMLC-IMRT. This QA program has been imple- FIG. 11 . ͑a͒ Overlay of IMRT dose distributions for the right lateral field of a nasopharynx case. The distribution from the treatment plan ͑solid͒ is almost indistinguishable from the distribution calculated from the log file ͑dotted͒. ͑b͒ Dose difference distribution ͑log file minus plan͒ indicates a maximum deviation of ϳ1%.
mented and improved in the last 5 years in the treatment of over 1000 IMRT patients.
